MSAC bestows mixed blessing on CSL
By Megan Brodie 12 months ago | In Cell and gene therapies, Companies, Reimbursement- 12 months ago
12 November 2025 A year after the MSAC rejected CSL Behring’s initial submission for its…
This is subscriber-only content. Please login to continue reading.